Pedro Henrique Xavier Nabuco de Araujo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pedro Henrique Xavier Nabuco de Araujo has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Paulo Manuel Pêgo-Fernandes
Universidade de São Paulo
15 shared publications - Ricardo Mingarini Terra
Thoracic Surgery Division, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
11 shared publications - Leticia Leone Lauricella
Universidade de São Paulo, Brasil
5 shared publications - Fabio Eiti Nishibe Minamoto
Thoracic Surgery Division, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
3 shared publications - Jose Ribas Milanez de Campos
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
3 shared publications - Juliana Rocha Mol Trindade
Universidade de São Paulo, Brasil
3 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 915
Implementation and preliminary clinical application of a robotic thoracic telesurgery program in a middle-income country: a structured pathway from simulation to clinical practice
Telesurgery may help overcome geographic disparities in access to specialized surgical care. Although recent studies confirm the technical feasibility of robotic thoracic telesurgery, most reports originate from highly controlled settings, and practical implementation within public healthcare systems remains scarce. We describe the development and preliminary clinical application of a robotic thoracic telesurgery program in a middle-income country, reported as a proof-of-implementation case series rather than a statistically validated model. A robotic thoracic telesurgery program was developed connecting the University of São Paulo Medical School (FMUSP) and University Hospital (HU-USP), approximately 10 km apart, using the Toumai® platform over the institutional fiber-optic network. Development included infrastructure deployment, preclinical network validation (28 robotic surgeons), safety-protocol development, and team training, culminating in two remotely performed procedures under a pre-defined, manufacturer-limited case allocation. A robotic wedge resection for pulmonary metastasis and a robotic left upper trisegmentectomy with systematic lymphadenectomy were completed entirely under remote control, with the surgeon at FMUSP and the patient at HU-USP. Neither procedure had communication interruptions, packet loss, conversion events, or intraoperative complications; maximum latency did not exceed 12 milliseconds. Chest tubes were removed on postoperative day 1 in both patients, with discharge on day 1 and 2, respectively. This early experience supports the technical feasibility of introducing robotic thoracic telesurgery within a public healthcare system through a structured implementation pathway. Given the small sample, conclusions remain preliminary; the model’s value lies not in extending distance, but in outlining a reproducible process for expanding access to specialized surgical expertise.
- 31 August 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 915
Open AccessImplementation and preliminary clinical application of a robotic thoracic telesurgery program in a middle-income country: a structured pathway from simulation to clinical practice
Telesurgery may help overcome geographic disparities in access to specialized surgical care. Although recent studies confirm the technical feasibility of robotic thoracic telesurgery, most reports originate from highly controlled settings, and practical implementation within public healthcare systems remains scarce. We describe the development and preliminary clinical application of a robotic thoracic telesurgery program in a middle-income country, reported as a proof-of-implementation case series rather than a statistically validated model. A robotic thoracic telesurgery program was developed connecting the University of São Paulo Medical School (FMUSP) and University Hospital (HU-USP), approximately 10 km apart, using the Toumai® platform over the institutional fiber-optic network. Development included infrastructure deployment, preclinical network validation (28 robotic surgeons), safety-protocol development, and team training, culminating in two remotely performed procedures under a pre-defined, manufacturer-limited case allocation. A robotic wedge resection for pulmonary metastasis and a robotic left upper trisegmentectomy with systematic lymphadenectomy were completed entirely under remote control, with the surgeon at FMUSP and the patient at HU-USP. Neither procedure had communication interruptions, packet loss, conversion events, or intraoperative complications; maximum latency did not exceed 12 milliseconds. Chest tubes were removed on postoperative day 1 in both patients, with discharge on day 1 and 2, respectively. This early experience supports the technical feasibility of introducing robotic thoracic telesurgery within a public healthcare system through a structured implementation pathway. Given the small sample, conclusions remain preliminary; the model’s value lies not in extending distance, but in outlining a reproducible process for expanding access to specialized surgical expertise.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 144 (6)
Tumor boards and multidisciplinary cancer treatment: history, evidence, impact, and future perspectives
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 144 (6)
Open AccessTumor boards and multidisciplinary cancer treatment: history, evidence, impact, and future perspectives
- Open Access
- 1 December 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (6) , e20250504
Hyperthermic intrathoracic chemotherapy in the management of pleural malignancies: current evidence, limitations, and future directions
- 1 December 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (6) , e20250504
Open AccessHyperthermic intrathoracic chemotherapy in the management of pleural malignancies: current evidence, limitations, and future directions
- Open Access
- 2 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (3) , e20240331
Results of radiotherapy for thymoma: retrospective cohort and propensity score matching analysis
Objective: Thymic tumors are a rare group of anterior mediastinal tumors. Surgery is the primary treatment. Adjuvant treatment is used in select cases. The purpose of this study was to evaluate the outcomes of patients with thymic tumors, submitted or not to radiotherapy, and identify risk factors that could impact the outcomes to better support patient selection for RT. Methods: This is a single institution retrospective cohort study. Patients with histologically proven thymoma or thymic carcinoma treated from July of 2009 to November of 2020 were included. Analysis was based on the use of radiation therapy (RT). Overall survival and disease-free survival were assessed from the date of diagnosis. To minimize selection bias, propensity score matching (PSM) regression using Kernel matching was used, estimated on the population for average treatment effect. Results: Overall, 101 patients were analyzed, with mean age at diagnosis of 54.6 years (range 25-84 years). Unfavorable histology and more advanced stages predominated in the cohort. Nevertheless, most (69.3%) were treated with radical intent. RT was delivered in 52.9% of these patients. Five-year OS, local progression and distant progression free survivals were 81.0%, 95.0% and 88.1%, respectively for the radical intent cohort. PSM showed that RT reduced the chances of death by 6.3% (matched sample size was 60, p = 0.02). Conclusions: In this retrospective cohort, RT had a positive impact in OS after PSM analysis. Prospective data regarding the role of RT in this disease is needed to validate these findings.
- 2 June 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (3) , e20240331
Open AccessResults of radiotherapy for thymoma: retrospective cohort and propensity score matching analysis
Objective: Thymic tumors are a rare group of anterior mediastinal tumors. Surgery is the primary treatment. Adjuvant treatment is used in select cases. The purpose of this study was to evaluate the outcomes of patients with thymic tumors, submitted or not to radiotherapy, and identify risk factors that could impact the outcomes to better support patient selection for RT. Methods: This is a single institution retrospective cohort study. Patients with histologically proven thymoma or thymic carcinoma treated from July of 2009 to November of 2020 were included. Analysis was based on the use of radiation therapy (RT). Overall survival and disease-free survival were assessed from the date of diagnosis. To minimize selection bias, propensity score matching (PSM) regression using Kernel matching was used, estimated on the population for average treatment effect. Results: Overall, 101 patients were analyzed, with mean age at diagnosis of 54.6 years (range 25-84 years). Unfavorable histology and more advanced stages predominated in the cohort. Nevertheless, most (69.3%) were treated with radical intent. RT was delivered in 52.9% of these patients. Five-year OS, local progression and distant progression free survivals were 81.0%, 95.0% and 88.1%, respectively for the radical intent cohort. PSM showed that RT reduced the chances of death by 6.3% (matched sample size was 60, p = 0.02). Conclusions: In this retrospective cohort, RT had a positive impact in OS after PSM analysis. Prospective data regarding the role of RT in this disease is needed to validate these findings.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20253553
Comparação de custos entre lobectomia pulmonar por videotoracoscopia e por cirurgia robótica: resultados de estudo brasileiro randomizado e controlado (Estudo BRAVO)
Introdução: A cirurgia torácica robótica tem muitos benefícios em potencial, mas o custo ainda é considerado um fator limitante para sua ampla disseminação em muitos países.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20253553
Open AccessComparação de custos entre lobectomia pulmonar por videotoracoscopia e por cirurgia robótica: resultados de estudo brasileiro randomizado e controlado (Estudo BRAVO)
Introdução: A cirurgia torácica robótica tem muitos benefícios em potencial, mas o custo ainda é considerado um fator limitante para sua ampla disseminação em muitos países.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20253553
A comparative cost analysis study of pulmonary robotic and video-assisted lobectomy: results of a randomized controlled trial (BRAVO Study)
Introduction: Robotic thoracic surgery has potential benefits, but the cost is still considered a limiting factor for its wide dissemination in most countries.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 52, e20253553
Open AccessA comparative cost analysis study of pulmonary robotic and video-assisted lobectomy: results of a randomized controlled trial (BRAVO Study)
Introduction: Robotic thoracic surgery has potential benefits, but the cost is still considered a limiting factor for its wide dissemination in most countries.
- Open Access
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Underutilization of adjuvant therapy in resected IB-III non-small-cell lung cancer risk model - analysis from the Brazilian registry of lung cancer
Category: Thoracic Oncology Introduction: Despite the proven survival benefits of adjuvant systemic therapy (AT) in resected non-small-cell lung cancer (NSCLC), its underutilization remains a concern.(–) Objecitve: This study aims to explore the extent to which socioeconomic disparities influence AT underutilization. Methods: Data from the Brazilian Registry of Lung Cancer (2009-2023), was queried for patients with complete surgical resected stage IB-III and stratified based on AT delivery. Demographic, clinical, and pathological variables were evaluated. Logistic regression model was performed. The model’s
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Open AccessUnderutilization of adjuvant therapy in resected IB-III non-small-cell lung cancer risk model - analysis from the Brazilian registry of lung cancer
Category: Thoracic Oncology Introduction: Despite the proven survival benefits of adjuvant systemic therapy (AT) in resected non-small-cell lung cancer (NSCLC), its underutilization remains a concern.(–) Objecitve: This study aims to explore the extent to which socioeconomic disparities influence AT underutilization. Methods: Data from the Brazilian Registry of Lung Cancer (2009-2023), was queried for patients with complete surgical resected stage IB-III and stratified based on AT delivery. Demographic, clinical, and pathological variables were evaluated. Logistic regression model was performed. The model’s
- Open Access
Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancer